A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer.
about
Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-Targeted Anticancer AgentsCancer therapy with phytochemicals: evidence from clinical studiesBezielle selectively targets mitochondria of cancer cells to inhibit glycolysis and OXPHOSIdentification and analysis of the active phytochemicals from the anti-cancer botanical extract BezielleDesigning a broad-spectrum integrative approach for cancer prevention and treatment.Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263.Herbs in hemato-oncological care: an evidence-based review of data on efficacy, safety, and drug interactions.Disruption of SHH signaling cascade by SBE attenuates lung cancer progression and sensitizes DDP treatmentBZL101, a phytochemical extract from the Scutellaria barbata plant, disrupts proliferation of human breast and prostate cancer cells through distinct mechanisms dependent on the cancer cell phenotype.Anti-angiogenic effect of the total flavonoids in Scutellaria barbata D. DonTraditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.Effects of Traditional Chinese Medicine on Chemotherapy-Induced Myelosuppression and Febrile Neutropenia in Breast Cancer PatientsWogonin induces reactive oxygen species production and cell apoptosis in human glioma cancer cells.Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy.Inductions of Caspase-, MAPK- and ROS-dependent Apoptosis and Chemotherapeutic Effects Caused by an Ethanol Extract of Scutellaria barbata D. Don in Human Gastric Adenocarcinom Cells.Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells.Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-β1 activity.Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1.Induction of apoptosis by total flavonoids from Scutellaria barbata D. Don in human hepatocarcinoma MHCC97-H cells via the mitochondrial pathway.Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: a population-based study.Bezielle (BZL101)-induced oxidative stress damage followed by redistribution of metabolic fluxes in breast cancer cells: a combined proteomic and metabolomic study.Cancer chemoprevention and therapy using chinese herbal medicine.Using the Chinese herb Scutellaria barbata against extensively drug-resistant Acinetobacter baumannii infections: in vitro and in vivo studies.Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention
P2860
Q26800890-A3134160-0BBD-4501-BFA6-E261DD9501A9Q26827407-BE45BA60-EF78-4A5E-8F52-7402E9BD82FAQ28480504-11D5FED0-04B0-40B3-B94B-CBF8B498D74FQ28732762-668BB5F9-C8D0-4050-A296-F16AA64432FAQ30736359-3A4E49D4-4805-4B7C-888F-5B736BE078A9Q33415723-964DA752-CD69-4B78-BAC1-17655315D7DEQ33596382-06BC7102-CBB0-409C-8851-961E6E04839CQ33689527-5E44F151-EBD6-484C-B022-65DD7C1641F8Q34581850-8D8C7CE2-1772-49E7-AEB0-454F3818C537Q34788355-1C7A0DCC-D420-4DD6-8C88-2FE2BAEBC07BQ35942893-20AC5D36-533D-4D30-BCDC-287E5F401A1CQ35996084-1CE64477-A0DC-4471-B079-84F9DCA74D87Q36202313-A685EE5B-6A32-4845-A55D-FBF66172D28FQ36959971-4B47E2BA-A3B8-46BD-BA4D-84998A157A7FQ37061127-225E8FD4-834E-4E49-9921-756665F912D7Q37397870-AE7C5C07-0315-4DD1-8F96-9D929D99BCD1Q37520219-30092E4E-5774-41D4-A19C-F8C6F61293F2Q38798742-40BE539E-C563-4FA3-9B40-1ACCFFAC825BQ39063793-CC37F96C-D969-4F1C-8CDD-603F9B2A7012Q39256176-D60024C3-139F-4133-A3FC-BB8A557A8A29Q39555290-A6B6411F-5358-4834-871D-6A52F7DEC166Q47327090-859E3A0B-3CEA-41C5-B38A-6FAEF65DA163Q55019482-791F09A0-FAE6-4B5B-80C1-755718F0BC38Q58793547-B6E438E5-8742-4416-B648-7478740A0045
P2860
A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
A phase 1B dose escalation tri ...... with metastatic breast cancer.
@ast
A phase 1B dose escalation tri ...... with metastatic breast cancer.
@en
A phase 1B dose escalation trial of Scutellaria barbata
@nl
type
label
A phase 1B dose escalation tri ...... with metastatic breast cancer.
@ast
A phase 1B dose escalation tri ...... with metastatic breast cancer.
@en
A phase 1B dose escalation trial of Scutellaria barbata
@nl
prefLabel
A phase 1B dose escalation tri ...... with metastatic breast cancer.
@ast
A phase 1B dose escalation tri ...... with metastatic breast cancer.
@en
A phase 1B dose escalation trial of Scutellaria barbata
@nl
P2093
P1476
A phase 1B dose escalation tri ...... with metastatic breast cancer.
@en
P2093
Alejandra T Perez
Charles L Shapiro
Deborah Grady
Debu Tripathy
Emma Shtivelman
Gretchen G Kimmick
Heather S Shaw
Isaac Cohen
Katherine A Caygill
P2888
P304
P356
10.1007/S10549-009-0678-5
P407
P577
2010-02-01T00:00:00Z
P6179
1042985635